After Hours
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours.
Stocks Info
The company is listed on the NASDAQ and operates within the Biotechnology industry segment. The current market capitalization of Viking Therapeutics Inc is $3.84B. A total of 3.46 million shares were traded on the day, compared to an average of 4.78M shares.
In the most recent transaction, Lian Brian sold 194,490 shares of VKTX for 42.75 per share on Jan 06 ’25. After the transaction, the President & CEO now owns 2,366,570 company shares. In a previous transaction on Jan 06 ’25, Mancini Marianna sold 54,215 shares at 42.75 per share. VKTX shares that Chief Operating Officer owns now total 374,134.
Among the insiders who sold shares, ZANTE GREG disposed of 50,309 shares on Jan 06 ’25 at a per-share price of $42.75. This resulted in the Chief Financial Officer holding 165,259 shares of VKTX after the transaction. In another insider transaction, GREG ZANTE bought 50,309 shares at $42.75 per share on Jan 06 ’25.
It has been observed that price targets are rarely accurate, but they can exert some influence from time to time, and are often accepted as valuable in the market. In terms of 52-week highs and lows, VKTX has a high of $99.41 and a low of $20.92.
As of this writing, VKTX has an earnings estimate of -$0.27 per share for the current quarter. EPS was calculated based on a consensus of 12.0 estimates, with a high estimate of -$0.22 per share and a lower estimate of -$0.34.
Balance Sheet Annually/Quarterly
An equity investor’s investment can be viewed on a balance sheet by looking at what assets and liabilities the company has. Investors can determine the company’s prospects by calculating its financial ratios based on this information. VKTX’s latest balance sheet shows that the firm has $202.10M in Cash & Short Term Investments as of fiscal 2021. There were $29.00k in debt and $8.78M in liabilities at the time. Its Book Value Per Share was $8.18, while its Total Shareholder’s Equity was $201.88M.
Analysts Opinion
There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for VKTX is Buy with a score of 5.00.
